<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="229290" id="root" date="1996-12-02" xml:lang="en">
<title>ISRAEL: RESEARCH ALERT - Teva is hold at $50.</title>
<headline>RESEARCH ALERT - Teva is hold at $50.</headline>
<dateline>TEL AVIV 1996-12-02</dateline>
<text>
<p>BZW Research Ltd has kept its buy recommendation for Israel's Teva Pharmaceutical Industries but said it expected the company's American Depositary Receipt (ADR) would peak at about $50.</p>
<p>&quot;As the (U.S. Food and Drug Administration) is finally expected to approve (Teva's multiple sclerosis treatment) Cop1, we believe that there is still some upside to the share price in the short term, and we therefore retain our buy recommendation,&quot; analysts Arnon Rubinstein and Franc Grigori said.</p>
<p>&quot;However, we now see less to go for long term, and would move to hold as the price approaches $50.&quot;</p>
<p>BZW noted that Teva's shares had risen 50 percent in the last three months, giving them a prospective price-to-earnings ratio of 16.8 for 1998. &quot;The upside is limited,&quot; it said.</p>
<p>BZW said Teva's share price was now dependent on the success of Cop1, awaiting final FDA approval. It said it assumed sales would reach $100 million next year and $180 million in 1998, giving it an estimated earnings per ADR of $2.77 in 1998.</p>
<p>- Tel Aviv newsroom, 972-3-537-2211</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="ISRAEL">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-02"/>
  </code>
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-02"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-02"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-02"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-02"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-12-02"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-12-02"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-12-02"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="TEL AVIV"/>
<dc element="dc.creator.location.country.name" value="ISRAEL"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
